Is genetic testing for IDH2 mutations recommended?
Genetic testing for IDH2 mutations is recommended for patients diagnosed with AML and other cancers where these mutations are prevalent. Identifying the presence of an IDH2 mutation can guide treatment decisions and potentially improve outcomes by allowing patients to benefit from targeted therapies.
